OraSure acquires Sherlock Biosciences; deal terms not disclosed in 8-K filing

ORASURE TECHNOLOGIES INC

OraSure announced acquisition of Sherlock Biosciences on December 19, 2024, but no deal value or financial terms provided.
The 8-K furnishes an investor presentation (Exhibit 99.1) with only a title slide; no new substantive details were given.
Acquisition press release referenced as Exhibit 99.2 but full text not included in the filing excerpt.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.